iShares US Pharmaceuticals ETF
IHE
IHE
101 hedge funds and large institutions have $317M invested in iShares US Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 47 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less capital invested
Capital invested by funds: $348M → $317M (-$30.7M)
66% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 47
Holders
101
Holding in Top 10
2
Calls
$860K
Puts
$391K
Top Buyers
| 1 | +$9.79M | |
| 2 | +$9.39M | |
| 3 | +$6.22M | |
| 4 |
Jane Street
New York
|
+$4.84M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.6M |
Top Sellers
| 1 | -$22.3M | |
| 2 | -$20.9M | |
| 3 | -$7.82M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$7.52M |
| 5 |
ST
Spinnaker Trust
Portland,
Maine
|
-$6.52M |